BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2617591)

  • 1. Mycobacterium ulcerans infection in Ashanti region, Ghana.
    van der Werf TS; van der Graaf WT; Groothuis DG; Knell AJ
    Trans R Soc Trop Med Hyg; 1989; 83(3):410-3. PubMed ID: 2617591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Present status of Buruli ulcer in Ghana, West Africa].
    Fukunishi Y
    Nihon Hansenbyo Gakkai Zasshi; 1999 Nov; 68(3):175-84. PubMed ID: 10659613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium ulcerans infections in Papua New Guinea: correlation of clinical, histological, and microbiologic features.
    Igo JD; Murthy DP
    Am J Trop Med Hyg; 1988 Mar; 38(2):391-2. PubMed ID: 2451445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buruli ulcer in Benin.
    Muelder K; Nourou A
    Lancet; 1990 Nov; 336(8723):1109-11. PubMed ID: 1977990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buruli ulcer disease.
    Wkly Epidemiol Rec; 2004 May; 79(20):194-9. PubMed ID: 15160612
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycobacterium ulcerans infection.
    van der Werf TS; van der Graaf WT; Tappero JW; Asiedu K
    Lancet; 1999 Sep; 354(9183):1013-8. PubMed ID: 10501380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of buruli ulcer disease: a four-year experience from four endemic districts in ghana.
    Adu E; Ampadu E; Acheampong D
    Ghana Med J; 2011 Mar; 45(1):4-9. PubMed ID: 21572818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin M antibody responses to Mycobacterium ulcerans allow discrimination between cases of active Buruli ulcer disease and matched family controls in areas where the disease is endemic.
    Okenu DM; Ofielu LO; Easley KA; Guarner J; Spotts Whitney EA; Raghunathan PL; Stienstra Y; Asamoa K; van der Werf TS; van der Graaf WT; Tappero JW; Ashford DA; King CH
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):387-91. PubMed ID: 15013992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buruli ulcer.
    Wansbrough-Jones M; Phillips R
    BMJ; 2005 Jun; 330(7505):1402-3. PubMed ID: 15961795
    [No Abstract]   [Full Text] [Related]  

  • 10. BCG vaccination against mycobacterium ulcerans infection (Buruli ulcer). First results of a trial in Uganda.
    Lancet; 1969 Jan; 1(7586):111-5. PubMed ID: 4178240
    [No Abstract]   [Full Text] [Related]  

  • 11. Buruli ulcer. Mycobacterium ulcerans infection.
    Wkly Epidemiol Rec; 2002 May; 77(20):165-6. PubMed ID: 12040740
    [No Abstract]   [Full Text] [Related]  

  • 12. Buruli ulcer disease. Mycobacterium ulcerans infection.
    Wkly Epidemiol Rec; 2002 Aug; 77(32):271-5. PubMed ID: 12194257
    [No Abstract]   [Full Text] [Related]  

  • 13. The pathology of Mycobacterium ulcerans infection.
    Hayman J; McQueen A
    Pathology; 1985 Oct; 17(4):594-600. PubMed ID: 4094789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual mycobacteria in 5 cases of opportunistic infections.
    Mezo A; Jennis F; McCarthy SW; Dawson DJ
    Pathology; 1979 Jul; 11(3):377-84. PubMed ID: 523179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of an IS2404-based nested PCR for diagnosis of Buruli ulcer disease in regions of Ghana where the disease is endemic.
    Stienstra Y; van der Werf TS; Guarner J; Raghunathan PL; Spotts Whitney EA; van der Graaf WT; Asamoa K; Tappero JW; Ashford DA; King CH
    J Clin Microbiol; 2003 Feb; 41(2):794-7. PubMed ID: 12574285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides.
    Phillips R; Adjei O; Lucas S; Benjamin N; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2866-70. PubMed ID: 15273093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beliefs and attitudes toward Buruli ulcer in Ghana.
    Stienstra Y; van der Graaf WT; Asamoa K; van der Werf TS
    Am J Trop Med Hyg; 2002 Aug; 67(2):207-13. PubMed ID: 12389949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana.
    Raghunathan PL; Whitney EA; Asamoa K; Stienstra Y; Taylor TH; Amofah GK; Ofori-Adjei D; Dobos K; Guarner J; Martin S; Pathak S; Klutse E; Etuaful S; van der Graaf WT; van der Werf TS; King CH; Tappero JW; Ashford DA
    Clin Infect Dis; 2005 May; 40(10):1445-53. PubMed ID: 15844067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease.
    Portaels F; Aguiar J; Debacker M; Guédénon A; Steunou C; Zinsou C; Meyers WM
    Infect Immun; 2004 Jan; 72(1):62-5. PubMed ID: 14688081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buruli ulcers: an emerging health problem in Ghana.
    Kwyer TA; Ampadu E
    Adv Skin Wound Care; 2006; 19(9):479-86. PubMed ID: 17132950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.